Creighton University School of MedicineDetroit, MI
56 - Efficacy and Safety of Seladelpar in Patients With Primary Biliary Cholangitis and Compensated Liver Cirrhosis in the Open-Label, Long-Term ASSURE Safety Study: Interim Results
Wednesday, October 30, 20248:40 AM – 8:50 AM ET